Tenon Medical, Inc. Earnings Per Share (Basic)
Tenon Medical, Inc. (TNON) reported Earnings Per Share (Basic) of -$12.35 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- Tenon Medical, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$12.35.
- Tenon Medical, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.31.
- Tenon Medical, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$289.19.
- Tenon Medical, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.40.
- Tenon Medical, Inc. earnings per share, basic for fiscal 2025 was -$1.70.
- Tenon Medical, Inc. earnings per share, basic for fiscal 2024 was -$11.26.
- Tenon Medical, Inc. earnings per share, basic for fiscal 2023 was -$68.64.
- Tenon Medical, Inc. earnings per share, basic for fiscal 2022 was -$23.62.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$12.35 10-Q · filed 2026-08-13 | -$23.16 10-Q · filed 2026-08-13 | -$1452.80 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1848.51 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2026-03-31 | -$0.31 10-Q · filed 2026-05-15 | -$599.02 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$987.38 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1681.93 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-12-31 | -$289.19 derived: net income ÷ weighted average shares · filed 2026-03-27 | -$684.03 derived: net income ÷ weighted average shares · filed 2026-03-27 | -$1468.78 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.70 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | -$0.40 10-Q · filed 2025-11-13 | -$1442.78 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.48 10-Q · filed 2025-11-13 | -$3368.43 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-06-30 | -$12.76 10-Q · filed 2026-08-13 | -$0.36 10-Q · filed 2025-08-13 | -$39.91 10-Q · filed 2026-08-13 | -$1.14 10-Q · filed 2025-08-13 | -$4081.00 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$6457.14 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||
| 2025-03-31 | -$1.01 10-Q · filed 2026-05-15 | -$1987.25 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$3890.99 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$6778.55 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||||
| 2024-12-31 | -$980.31 derived: net income ÷ weighted average shares · filed 2026-03-27 | -$3115.25 derived: net income ÷ weighted average shares · filed 2026-03-27 | -$6738.82 derived: net income ÷ weighted average shares · filed 2026-03-27 | -$11.26 10-K · filed 2026-03-27 | ||||
| 2024-09-30 | -$3.63 10-Q · filed 2025-11-13 | -$10416.05 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$18.60 10-Q · filed 2025-11-13 | -$27168.32 derived: net income ÷ weighted average shares · filed 2025-11-13 | ||||
| 2024-06-30 | -$8.16 10-Q · filed 2025-08-13 | -$1.02 10-Q · filed 2024-08-13 | -$17.92 10-Q · filed 2025-08-13 | -$2.24 10-Q · filed 2024-08-13 | -$27653.54 derived: net income ÷ weighted average shares · filed 2025-08-13 | -$38845.94 derived: net income ÷ weighted average shares · filed 2025-08-13 | ||
| 2024-03-31 | -$10.02 10-Q · filed 2025-05-13 | -$1.25 10-Q · filed 2024-05-15 | -$19910.98 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$31413.97 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$25312.72 derived: net income ÷ weighted average shares · filed 2025-05-13 | |||
| 2023-12-31 | -$9886.44 derived: net income ÷ weighted average shares · filed 2025-03-26 | -$21481.73 derived: net income ÷ weighted average shares · filed 2025-03-26 | -$16912.95 derived: net income ÷ weighted average shares · filed 2025-03-26 | -$68.64 10-K · filed 2025-03-26 | -$8.59 10-K · filed 2024-03-29 | |||
| 2023-09-30 | -$11.69 10-Q · filed 2024-11-14 | -$1.46 10-Q · filed 2023-11-14 | -$9581.13 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$63.18 10-Q · filed 2024-11-14 | -$7.91 10-Q · filed 2023-11-14 | -$21188.96 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||
| 2023-06-30 | -$3.28 10-Q · filed 2024-08-13 | -$0.33 10-Q · filed 2023-08-11 | -$7.50 10-Q · filed 2024-08-13 | -$0.75 10-Q · filed 2023-08-11 | -$14354.79 derived: net income ÷ weighted average shares · filed 2024-08-13 | -$17253.58 derived: net income ÷ weighted average shares · filed 2024-08-13 | ||
| 2023-03-31 | -$4.30 10-Q · filed 2024-05-15 | -$0.43 10-Q · filed 2023-05-09 | -$11309.95 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$14134.48 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$7253.43 derived: net income ÷ weighted average shares · filed 2024-05-15 | |||
| 2022-12-31 | -$7007.98 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$9836.59 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$4655.42 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$23.62 10-K · filed 2024-03-29 | -$2.36 10-K · filed 2023-03-10 | |||
| 2022-09-30 | -$2.82 10-Q · filed 2023-11-14 | -$0.28 10-Q · filed 2022-11-10 | -$1814.16 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$15.91 10-Q · filed 2023-11-14 | -$1.59 10-Q · filed 2022-11-10 | -$4800.42 derived: net income ÷ weighted average shares · filed 2023-11-14 | ||
| 2022-06-30 | -$0.65 10-Q · filed 2023-08-11 | -$1.66 10-Q · filed 2023-08-11 | -$3075.72 derived: net income ÷ weighted average shares · filed 2023-08-11 | -$4594.41 derived: net income ÷ weighted average shares · filed 2023-08-11 | ||||
| 2022-03-31 | -$2.38 10-Q · filed 2023-05-09 | -$5200.20 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$7750.43 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$9822.26 derived: net income ÷ weighted average shares · filed 2023-05-09 | ||||
| 2021-12-31 | -$2819.44 derived: net income ÷ weighted average shares · filed 2023-03-10 | -$5379.35 derived: net income ÷ weighted average shares · filed 2023-03-10 | -$7451.58 derived: net income ÷ weighted average shares · filed 2023-03-10 | -$7.81 10-K · filed 2023-03-10 | ||||
| 2021-09-30 | -$2.55 10-Q · filed 2022-11-10 | -$4580.90 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$4.85 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | -$2.01 10-Q · filed 2022-08-12 | -$2.21 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |